United States Inhalation & Nasal Spray Generic Drugs Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Inhalation & Nasal Spray Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Inhalation & Nasal Spray Generic Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Inhalation & Nasal Spray Generic Drugs Overall Market Size
2.1 United States Inhalation & Nasal Spray Generic Drugs Market Size: 2021 VS 2027
2.2 United States Inhalation & Nasal Spray Generic Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Inhalation & Nasal Spray Generic Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Inhalation & Nasal Spray Generic Drugs Players in United States Market
3.2 Top United States Inhalation & Nasal Spray Generic Drugs Companies Ranked by Revenue
3.3 United States Inhalation & Nasal Spray Generic Drugs Revenue by Companies
3.4 United States Inhalation & Nasal Spray Generic Drugs Sales by Companies
3.5 United States Inhalation & Nasal Spray Generic Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Inhalation & Nasal Spray Generic Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Inhalation & Nasal Spray Generic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inhalation & Nasal Spray Generic Drugs Players in United States Market
3.8.1 List of Tier 1 Inhalation & Nasal Spray Generic Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 Inhalation & Nasal Spray Generic Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Inhalation & Nasal Spray Generic Drugs Market Size Markets, 2021 & 2027
4.1.2 Corticosteroids
4.1.3 Bronchodilators
4.1.4 Combinations
4.1.5 Decongestant Sprays
4.1.6 Others
4.2 By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue & Forecasts
4.2.1 By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue, 2016-2021
4.2.2 By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue, 2022-2027
4.2.3 By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States Inhalation & Nasal Spray Generic Drugs Sales & Forecasts
4.3.1 By Type - United States Inhalation & Nasal Spray Generic Drugs Sales, 2016-2021
4.3.2 By Type - United States Inhalation & Nasal Spray Generic Drugs Sales, 2022-2027
4.3.3 By Type - United States Inhalation & Nasal Spray Generic Drugs Sales Market Share, 2016-2027
4.4 By Type - United States Inhalation & Nasal Spray Generic Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Inhalation & Nasal Spray Generic Drugs Market Size, 2021 & 2027
5.1.2 Asthma
5.1.3 COPD
5.1.4 Allergic Rhinitis
5.1.5 Others
5.2 By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue & Forecasts
5.2.1 By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue, 2016-2021
5.2.2 By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue, 2022-2027
5.2.3 By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States Inhalation & Nasal Spray Generic Drugs Sales & Forecasts
5.3.1 By Application - United States Inhalation & Nasal Spray Generic Drugs Sales, 2016-2021
5.3.2 By Application - United States Inhalation & Nasal Spray Generic Drugs Sales, 2022-2027
5.3.3 By Application - United States Inhalation & Nasal Spray Generic Drugs Sales Market Share, 2016-2027
5.4 By Application - United States Inhalation & Nasal Spray Generic Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 Teva Inhalation & Nasal Spray Generic Drugs Product Description
6.1.5 Teva Recent Developments
6.2 Sandoz (Novartis AG)
6.2.1 Sandoz (Novartis AG) Corporation Information
6.2.2 Sandoz (Novartis AG) Overview
6.2.3 Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Product Description
6.2.5 Sandoz (Novartis AG) Recent Developments
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Overview
6.3.3 Mylan Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 Mylan Inhalation & Nasal Spray Generic Drugs Product Description
6.3.5 Mylan Recent Developments
6.4 Allergan PLC
6.4.1 Allergan PLC Corporation Information
6.4.2 Allergan PLC Overview
6.4.3 Allergan PLC Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 Allergan PLC Inhalation & Nasal Spray Generic Drugs Product Description
6.4.5 Allergan PLC Recent Developments
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Overview
6.5.3 Cipla Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.5.4 Cipla Inhalation & Nasal Spray Generic Drugs Product Description
6.5.5 Cipla Recent Developments
6.6 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Overview
6.6.3 Akorn Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.6.4 Akorn Inhalation & Nasal Spray Generic Drugs Product Description
6.6.5 Akorn Recent Developments
6.7 Apotex
6.7.1 Apotex Corporation Information
6.7.2 Apotex Overview
6.7.3 Apotex Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.7.4 Apotex Inhalation & Nasal Spray Generic Drugs Product Description
6.7.5 Apotex Recent Developments
6.8 Sun Pharma (Ranbaxy)
6.8.1 Sun Pharma (Ranbaxy) Corporation Information
6.8.2 Sun Pharma (Ranbaxy) Overview
6.8.3 Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.8.4 Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Product Description
6.8.5 Sun Pharma (Ranbaxy) Recent Developments
6.9 Nephron Pharma
6.9.1 Nephron Pharma Corporation Information
6.9.2 Nephron Pharma Overview
6.9.3 Nephron Pharma Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.9.4 Nephron Pharma Inhalation & Nasal Spray Generic Drugs Product Description
6.9.5 Nephron Pharma Recent Developments
6.10 Beximco Pharma
6.10.1 Beximco Pharma Corporation Information
6.10.2 Beximco Pharma Overview
6.10.3 Beximco Pharma Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.10.4 Beximco Pharma Inhalation & Nasal Spray Generic Drugs Product Description
6.10.5 Beximco Pharma Recent Developments
6.11 Hikma (Roxane)
6.11.1 Hikma (Roxane) Corporation Information
6.11.2 Hikma (Roxane) Overview
6.11.3 Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.11.4 Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Product Description
6.11.5 Hikma (Roxane) Recent Developments
6.12 XIANJU PHARMA
6.12.1 XIANJU PHARMA Corporation Information
6.12.2 XIANJU PHARMA Overview
6.12.3 XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Sales and Revenue in United States Market (2016-2021)
6.12.4 XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Product Description
6.12.5 XIANJU PHARMA Recent Developments
7 United States Inhalation & Nasal Spray Generic Drugs Production Capacity, Analysis
7.1 United States Inhalation & Nasal Spray Generic Drugs Production Capacity, 2016-2027
7.2 Inhalation & Nasal Spray Generic Drugs Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Inhalation & Nasal Spray Generic Drugs Supply Chain Analysis
9.1 Inhalation & Nasal Spray Generic Drugs Industry Value Chain
9.2 Inhalation & Nasal Spray Generic Drugs Upstream Market
9.3 Inhalation & Nasal Spray Generic Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Inhalation & Nasal Spray Generic Drugs Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Inhalation & Nasal Spray Generic Drugs in United States Market
Table 2. Top Inhalation & Nasal Spray Generic Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Inhalation & Nasal Spray Generic Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Inhalation & Nasal Spray Generic Drugs Revenue Share by Companies, 2016-2021
Table 5. United States Inhalation & Nasal Spray Generic Drugs Sales by Companies, (M Units), 2016-2021
Table 6. United States Inhalation & Nasal Spray Generic Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Inhalation & Nasal Spray Generic Drugs Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Inhalation & Nasal Spray Generic Drugs Product Type
Table 9. List of Tier 1 Inhalation & Nasal Spray Generic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Inhalation & Nasal Spray Generic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Corticosteroids
Table 12. Major Manufacturers of Bronchodilators
Table 13. By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Inhalation & Nasal Spray Generic Drugs Sales (M Units), 2016-2021
Table 17. By Type - United States Inhalation & Nasal Spray Generic Drugs Sales (M Units), 2022-2027
Table 18. By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Inhalation & Nasal Spray Generic Drugs Sales (M Units), 2016-2021
Table 22. By Application - United States Inhalation & Nasal Spray Generic Drugs Sales (M Units), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Teva Inhalation & Nasal Spray Generic Drugs Product
Table 27. Teva Recent Developments
Table 28. Sandoz (Novartis AG) Corporation Information
Table 29. Sandoz (Novartis AG) Description and Major Businesses
Table 30. Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Product
Table 32. Sandoz (Novartis AG) Recent Developments
Table 33. Mylan Corporation Information
Table 34. Mylan Description and Major Businesses
Table 35. Mylan Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Mylan Inhalation & Nasal Spray Generic Drugs Product
Table 37. Mylan Recent Developments
Table 38. Allergan PLC Corporation Information
Table 39. Allergan PLC Description and Major Businesses
Table 40. Allergan PLC Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Allergan PLC Inhalation & Nasal Spray Generic Drugs Product
Table 42. Allergan PLC Recent Developments
Table 43. Cipla Corporation Information
Table 44. Cipla Description and Major Businesses
Table 45. Cipla Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Cipla Inhalation & Nasal Spray Generic Drugs Product
Table 47. Cipla Recent Developments
Table 48. Akorn Corporation Information
Table 49. Akorn Description and Major Businesses
Table 50. Akorn Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Akorn Inhalation & Nasal Spray Generic Drugs Product
Table 52. Akorn Recent Developments
Table 53. Apotex Corporation Information
Table 54. Apotex Description and Major Businesses
Table 55. Apotex Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Apotex Inhalation & Nasal Spray Generic Drugs Product
Table 57. Apotex Recent Developments
Table 58. Sun Pharma (Ranbaxy) Corporation Information
Table 59. Sun Pharma (Ranbaxy) Description and Major Businesses
Table 60. Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Product
Table 62. Sun Pharma (Ranbaxy) Recent Developments
Table 63. Nephron Pharma Corporation Information
Table 64. Nephron Pharma Description and Major Businesses
Table 65. Nephron Pharma Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Nephron Pharma Inhalation & Nasal Spray Generic Drugs Product
Table 67. Nephron Pharma Recent Developments
Table 68. Beximco Pharma Corporation Information
Table 69. Beximco Pharma Description and Major Businesses
Table 70. Beximco Pharma Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Beximco Pharma Inhalation & Nasal Spray Generic Drugs Product
Table 72. Beximco Pharma Recent Developments
Table 73. Hikma (Roxane) Corporation Information
Table 74. Hikma (Roxane) Description and Major Businesses
Table 75. Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Product
Table 77. Hikma (Roxane) Recent Developments
Table 78. XIANJU PHARMA Corporation Information
Table 79. XIANJU PHARMA Description and Major Businesses
Table 80. XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Product
Table 82. XIANJU PHARMA Recent Developments
Table 83. Inhalation & Nasal Spray Generic Drugs Production Capacity (M Units) of Key Manufacturers in United States Market, 2019-2021 (M Units)
Table 84. United States Inhalation & Nasal Spray Generic Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 85. Inhalation & Nasal Spray Generic Drugs Market Opportunities & Trends in United States Market
Table 86. Inhalation & Nasal Spray Generic Drugs Market Drivers in United States Market
Table 87. Inhalation & Nasal Spray Generic Drugs Market Restraints in United States Market
Table 88. Inhalation & Nasal Spray Generic Drugs Raw Materials
Table 89. Inhalation & Nasal Spray Generic Drugs Raw Materials Suppliers in United States Market
Table 90. Typical Inhalation & Nasal Spray Generic Drugs Downstream
Table 91. Inhalation & Nasal Spray Generic Drugs Downstream Clients in United States Market
Table 92. Inhalation & Nasal Spray Generic Drugs Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Inhalation & Nasal Spray Generic Drugs Product Picture
Figure 2. Inhalation & Nasal Spray Generic Drugs Segment by Type
Figure 3. Inhalation & Nasal Spray Generic Drugs Segment by Application
Figure 4. United States Inhalation & Nasal Spray Generic Drugs Market Overview: 2020
Figure 5. United States Inhalation & Nasal Spray Generic Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Inhalation & Nasal Spray Generic Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Inhalation & Nasal Spray Generic Drugs Sales in United States Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Inhalation & Nasal Spray Generic Drugs Revenue in 2020
Figure 9. Corticosteroids Product Picture
Figure 10. Bronchodilators Product Picture
Figure 11. Combinations Product Picture
Figure 12. Decongestant Sprays Product Picture
Figure 13. Others Product Picture
Figure 14. By Type - United States Inhalation & Nasal Spray Generic Drugs Sales Market Share, 2016-2027
Figure 15. By Type - United States Inhalation & Nasal Spray Generic Drugs Revenue Market Share, 2016-2027
Figure 16. By Type - United States Inhalation & Nasal Spray Generic Drugs Price (USD/Unit), 2016-2027
Figure 17. Asthma
Figure 18. COPD
Figure 19. Allergic Rhinitis
Figure 20. Others
Figure 21. By Application - United States Inhalation & Nasal Spray Generic Drugs Sales Market Share, 2016-2027
Figure 22. By Application - United States Inhalation & Nasal Spray Generic Drugs Revenue Market Share, 2016-2027
Figure 23. By Application - United States Inhalation & Nasal Spray Generic Drugs Price (USD/Unit), 2016-2027
Figure 24. Teva Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Sandoz (Novartis AG) Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Mylan Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Allergan PLC Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Cipla Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Akorn Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Apotex Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Sun Pharma (Ranbaxy) Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Nephron Pharma Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Beximco Pharma Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Hikma (Roxane) Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. XIANJU PHARMA Inhalation & Nasal Spray Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. United States Inhalation & Nasal Spray Generic Drugs Production Capacity (M Units), 2016-2027
Figure 37. Inhalation & Nasal Spray Generic Drugs Industry Value Chain
Figure 38. Marketing Channels